Authors: DEBREGEAS B DUCHIER J

Citation: B. Debregeas et J. Duchier, EFFICACY AND TOLERABILITY OF ONCE-DAILY SUSTAINED-RELEASE AND CONVENTIONAL DILTIAZEM IN PATIENTS WITH STABLE ANGINA-PECTORIS, Clinical drug investigation, 13(2), 1997, pp. 59-65

Authors: DUCHIER J AURICHE C GUINOT P

Citation: J. Duchier et al., EFFECT OF BN-50730, A SPECIFIC PAF ANTAGONIST, ON PAF-INDUCED PLATELET-AGGREGATION AND SKIN-RESPONSES IN HEALTHY-HUMAN VOLUNTEERS, Drug investigation, 8(2), 1994, pp. 95-103

Authors: AUBIER M CANET E ARNAUD F",BERDAH,"DUCHIER J DUROUX P FOURNIER M JIROUNAJOU JL LEPECQ JB MARTHAN R PAPO M RENAUD S SCHLEMMER B

Citation: M. Aubier et al., METHODOLOGY IN EVALUATION OF DRUG IN CHRONIC-BRONCHITIS, Therapie, 49(3), 1994, pp. 245-249

Authors: DAHAN R JAILLON P LEHNER JP CAZOR JL CLOARECBLANCHARD L DAHAN R DUCHIER J GUINOT P JAILLON P LEHNER JP LOEB F MACQUINMAVIER C PUECH A ROLAND E ROUVEIX B TEULEESPIE M THULLIEZ C VITOU P

Citation: R. Dahan et al., HOW TO PREDICT THE THERAPEUTIC DOSE RANGE TO BE TESTED IN PHASE-III CLINICAL-TRIALS, Therapie, 48(4), 1993, pp. 297-301

Authors: DELHOTALLANDES B FLOUVAT B DUCHIER J MOLINIE P DELLATOLAS F LEMAIRE M

Citation: B. Delhotallandes et al., PHARMACOKINETICS OF LANSOPRAZOLE IN PATIENTS WITH RENAL OR LIVER-DISEASE OF VARYING SEVERITY, European Journal of Clinical Pharmacology, 45(4), 1993, pp. 367-371